Global Orthopedic Regenerative Surgical Products Market is expected to foresee significant growth. North America to lead the growth!

Global orthopedic regenerative surgical products market is expected to register a CAGR of approx. 4% over the period of 2022-2028. Regenerative orthopedics help treat discomfort and pain in the musculoskeletal system and improve the healing of orthopedic conditions, such as ligaments, tendon injuries, muscles, bones, knee meniscus, intervertebral discs life, and cartilage. These parts of the body have a relatively low capacity for self-healing. Regenerative orthopedic surgical products help these tissues heal faster. Orthopedic regenerative surgical products can help some patients avoid orthopedic surgery altogether. The rapid growth of the geriatric population is an indication of the rise of various bone-related diseases including arthritis and spinal cord diseases, among others. Arthritis is the most common disease, mainly in the obese and elderly group. Hence, the increasing number of arthritis cases is driving the market in the coming years. For instance, in 2022, according to very wealth.com, More than 22% of American adults (over 52.5 million people) have arthritis or another rheumatic condition diagnosed by a doctor. 7.3% of people aged 18-44 have doctor-diagnosed arthritis; 30.3% of people aged 45-64; and 49.7% of those over 65, and by 2030, the number of people with arthritis (adults 18 years and older) is expected to rise to 67 million. Furthermore, the increase in accidental cases and osteoporotic fractures are also some of the other factors contributing to the growth of the orthopedic regenerative surgical products market.

For a detailed analysis of the Global Orthopedic Regenerative Surgical Products Market browse through – https://univdatos.com/report/orthopedic-regenerative-surgical-products-market/

Based on product, the market is classified into allografts, synthetic, cell-based, and viscosupplements. Amongst these, the viscosupplement category accounted for a significant share of the market owing to the rising incidence of knee pain, osteoarthritis, and related symptoms and an increase in product availability driving the growth of this segment.

Based on application, the market is categorized into knee surgeries, hip surgeries, spine surgeries, and others. Among these, knee surgeries are expected to witness the highest CAGR during the forecast period. increasing surgical procedures, geriatric patients, and the incidence of trauma cases are likely to aid the segment’s growth.

For a better understanding of the market adoption of orthopedic regenerative surgical products market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the orthopedic regenerative surgical products industry and generated revenue owing to the presence of well-established market players and technologically advanced healthcare facilities in the region.
Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=28435

Some of the major players operating in the market include Anika Therapeutics, Inc., Vericel Corporation, Baxter, Zimmer Biomet, Stryker, Smith & Nephew, AlloSource, Amniox Medical, Inc., VSY Biotechnology, Aptissen S.A.

Global Orthopedic Regenerative Surgical Products Market Segmentation

Market Insight, by Product

• Allografts
• Synthetic
• Cell-based
• Viscosupplements

Market Insight, by Application

• Orthopedic pain management
• Trauma Repair
• Cartilage and tendon repair
• Joint reconstruction
• Others

Market Insight, by End-Users

• Hospitals
• Ambulatory Surgical Centers
• Others

Market Insight, by Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Australia
  • Japan
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• Anika Therapeutics, Inc.
• Vericel Corporation
• Baxter
• Zimmer Biomet
• Stryker
• Smith & Nephew
• AlloSource
• Amniox Medical, Inc.
• VSY Biotechnology
• Aptissen S.A.